Cargando…

Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis

PURPOSE: The aim of this study was to evaluate the diagnostic performance of choline positron emission tomography/computed tomography (PET/CT) for the detection of bone metastasis in patients with prostate cancer. METHODS: MEDLINE, EMBASE and the Cochrane Library were searched up to 20 February 2018...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yu, Wang, Ling, Hu, Junjie, Feng, Dehong, Xu, Lijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128558/ https://www.ncbi.nlm.nih.gov/pubmed/30192819 http://dx.doi.org/10.1371/journal.pone.0203400

Ejemplares similares

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
por: Huysse, Wouter, et al.
Publicado: (2017)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience
por: Nyk, Łukasz, et al.
Publicado: (2022)

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
por: Wang, Rang, et al.
Publicado: (2021)

Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review
por: Skanjeti, Andrea, et al.
Publicado: (2011)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
por: Olivari, Laura, et al.
Publicado: (2020)

False-Negative Bone Scan and Choline Pet/Ct Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant
por: Al-Tamimi, Ammad, et al.
Publicado: (2012)

Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2017)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy
por: Metz, Raphaël, et al.
Publicado: (2023)

Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
por: Sollini, Martina, et al.
Publicado: (2016)

Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies
por: Liu, Fanxiao, et al.
Publicado: (2021)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer
por: Huang, Shi-ming, et al.
Publicado: (2018)

Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
por: Bin, Xu, et al.
Publicado: (2020)

Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
por: Kawanaka, Yusuke, et al.
Publicado: (2018)

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT
por: Gergelis, Kimberly R., et al.
Publicado: (2019)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
por: Deijen, Charlotte L., et al.
Publicado: (2021)

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?
por: Jadvar, Hossein
Publicado: (2012)

Pre-treatment (18)F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancer
por: Kjölhede, Henrik, et al.
Publicado: (2018)

Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
por: Gómez-de la Fuente, Francisco J., et al.
Publicado: (2019)

A retrospective analysis of the diagnostic performance of (11)C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism
por: Noltes, M. E., et al.
Publicado: (2021)

Comparison of (68)Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
por: Regula, Naresh, et al.
Publicado: (2022)

PET/CT analysis of 21 patients with breast cancer: physiological distribution of (18)F-choline and diagnostic pitfalls
por: Ahmad Saad, Fathinul Fikri, et al.
Publicado: (2018)

Diagnostic efficacy of PET/CT in bone tumors
por: Han, Songhui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_91i16hndpr3riob1v88oddheu5